Sign In
Buy TTI
$7.70
+0.0800 (+1.05%)
At Close: Jul 31, 2026
Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update
04:01pm, Tuesday, 31'st Mar 2026
Results from healthy volunteer study of next-generation STAT3 inhibitor, TTI-109, on track for Q2 2026 Topline data from Phase 2 trial of TTI-101 in hepatocellular carcinoma (HCC) are anticipated in H
Critical Review: Tetra Technologies (NYSE:TTI) versus Subsea 7 (OTCMKTS:SUBCY)
02:30am, Saturday, 28'th Mar 2026
Subsea 7 (OTCMKTS:SUBCY - Get Free Report) and Tetra Technologies (NYSE: TTI - Get Free Report) are both energy companies, but which is the superior business? We will contrast the two businesses based
Acuitas Investments LLC Acquires Shares of 736,170 Tetra Technologies, Inc. $TTI
03:25am, Wednesday, 18'th Mar 2026
Acuitas Investments LLC bought a new position in Tetra Technologies, Inc. (NYSE: TTI) in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The institutio
TETRA TECHNOLOGIES, INC. TO PARTICIPATE IN THE PIPER SANDLER 26TH ANNUAL ENERGY CONFERENCE
03:02pm, Wednesday, 04'th Mar 2026
SPRING, Texas, March 4, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced that Brady Murphy, Chief Executive Officer; Elijio Serrano, Chief Financial Office
TETRA Technologies, Inc. (TTI) Q4 2025 Earnings Call Transcript
04:37am, Friday, 27'th Feb 2026
TETRA Technologies, Inc. (TTI) Q4 2025 Earnings Call Transcript
TETRA TECHNOLOGIES, INC. ANNOUNCES FOURTH-QUARTER AND STRONG FULL-YEAR 2025 RESULTS AND PROVIDES UPDATE ON STRATEGIC INITIATIVES
05:07pm, Wednesday, 25'th Feb 2026
SPRING, Texas, Feb. 25, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced financial results for the three and twelve months ended December 31, 2025. Fourth-
Tetra Technologies (TTI) Projected to Post Quarterly Earnings on Wednesday
02:32am, Wednesday, 18'th Feb 2026
Tetra Technologies (NYSE: TTI - Get Free Report) is projected to post its Q4 2025 results after the market closes on Wednesday, February 25th. Analysts expect Tetra Technologies to post earnings of $0
Thiogenesis Therapeutics Announces Investigator-Initiated Study in Nephropathic Cystinosis and Provides Program Update
09:00am, Monday, 02'nd Feb 2026
San Diego, California--(Newsfile Corp. - February 2, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company develop
TETRA TECHNOLOGIES, INC. ANNOUNCES DATE FOR FOURTH QUARTER AND FULL YEAR 2025 EARNINGS CONFERENCE CALL
08:00am, Monday, 02'nd Feb 2026
SPRING, Texas, Feb. 2, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) will release Fourth Quarter and Full Year 2025 results after the market close on Wednesday,
Tetra Technologies (NYSE:TTI) Share Price Passes Above 200 Day Moving Average – What’s Next?
04:10am, Friday, 30'th Jan 2026
Tetra Technologies, Inc. (NYSE: TTI - Get Free Report) passed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $6.87 and traded as high as $12.00.
Acuitas Investments LLC Makes New Investment in Tetra Technologies, Inc. $TTI
03:02am, Friday, 30'th Jan 2026
Acuitas Investments LLC acquired a new stake in Tetra Technologies, Inc. (NYSE: TTI) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The
Pullen Sells $3 Million of TETRA Technologies Stock
01:23pm, Thursday, 29'th Jan 2026
Sold 384,274 shares of TETRA Technologies; estimated transaction value $2.96 million (based on quarterly average pricing). Quarter-end position value declined by $1.1 million, reflecting both trading
Stone House Investment Management, LLC Buys 4,190 Shares of Tetra Technologies Inc (TTI)
06:10pm, Wednesday, 21'st Jan 2026
Summary Stone House Investment Management, LLC initiated a new position in Tetra Technologies Inc(TTI), purchasing 4,190 shares valued at approximately
Pre-Market Stock Futures: The futures are trading lower again after a dreadful risk-off day across Wall Street, where all major indices finished the day solidly lower. The combination of President Tru
Thiogenesis Therapeutics' MELAS Abstract Accepted for Late-Breaking News Presentation at Mitocon 2026
09:00am, Tuesday, 13'th Jan 2026
San Diego, California--(Newsfile Corp. - January 13, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company develop
